Korea Trade Commission Launches Kickback Probes Of Pharmaceutical Firms Following Similar Action By Drug Regulators
This article was originally published in PharmAsia News
Executive Summary
SEOUL - To underscore the government's crackdown on kickbacks ahead of the implementation of a new law on the topic slated to become effective in late November, South Korea's Fair Trade Commission is launching probes of several Korean pharmaceutical firms suspected of providing illicit payments to hospitals and doctors
You may also be interested in...
Korean Government Launches Strongest-ever Drive To Root Out Rebates
SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November
Korean Government Launches Strongest-ever Drive To Root Out Rebates
SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November
Korea FDA Raids Chong Kun Dang On Kickback Allegations
SEOUL - Reflecting the Korean government's bid to crack down on medical kickbacks, Korea FDA investigators, armed with a search and seizure warrant, raided the headquarters and four branches of Chong Kun Dang Pharmaceutical following allegations that the pharma is offering illegal rebates ahead of the launch of the anti-rebate law Nov. 28